Venezuela Medical Device Registration Dossier 2026: Structure and Assembly

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

A Venezuelan registration dossier is assembled from two large blocks, administrative documents and technical documents, and the two are reviewed under different logic. The administrative block is checked for the completeness of its chain. The technical block is checked for internal consistency. Sponsors who treat the dossier as one undifferentiated pile of paper usually prepare the strongest documents first and discover the structural gap last, when the file has already entered the review queue.

GRZAN’s assessment: build the skeleton first and fill it afterwards; that sequence is more efficient than preparing documents one by one. Most deficiency letters do not state that a document is missing. They state that the link between documents has broken: a power of attorney whose scope does not cover the application at hand, a certificate of free sale whose product name does not match the technical file, a quality certificate whose scope excludes the manufacturing site actually declared. Problems of this kind surface only at the level of the skeleton, because each document read on its own looks correct.

The practical consequence is that dossier assembly should be planned as an architectural exercise in four layers, each with its own reuse profile and its own failure mode, rather than as a checklist of documents to be collected. Once the layers are defined and numbered, broken links become visible before submission instead of after a rejection, and the same numbering later supports renewals and variations without rebuilding the file.

2. Legal basis

Regulation or documentReference numberPublication dateProvision or key point
Ley de Medicamentos (Medicines Law)Gaceta Oficial N° 37.006August 3, 2000Article 18: registration obligation and publication mechanism
Circular N° DGSACS/0002/2025DGSACS/0002/2025October 28, 2025Procedure handled through the COMEX platform
Decreto N° 4.944 (customs tariff)G.O. N° 6.804 ExtraordinarioApril 25, 2024Article 37: the classification outcome determines the applicable legal regime
Circular N° DGSACS-008/2026DGSACS-008/2026July 9, 2026Destination labeling must be authorized

Scope statement: the dossier skeleton in this section is consolidated from industry comparison material on Latin American medical device registration requirements describing Venezuela, and is marked as a practical estimate. The current checklist issued by the receiving window must be confirmed before project execution.

3. Expert insights

Insight one: the four-layer module division carries different reuse rates and different failure risks. Treating all four layers as equally important is the most common planning error, because the effort invested in each layer buys a very different amount of resilience.

ModuleMain contentReuse rateMain failure risk
Administrative moduleApplication form, power of attorney, representative credentials, corporate documentsHighNotarization or legalization expired; scope of authority does not cover the matter
Quality system moduleISO 13485 or ISO 9001, GMP certificateHighCertificate expired; scope does not include this product
Product moduleTechnical description, labeling, instructions for use, bill of materialsMediumInconsistent with the technical file
Evidence modulePerformance, stability, clinical and sterilization validationLowInsufficient remaining validity; version mismatch

The administrative and quality system modules are reused across products and across applications, so an investment in their correctness pays back on every subsequent filing. The evidence module is almost entirely product specific and must be rebuilt for each submission. Allocating budget in proportion to reuse, rather than in proportion to how difficult a document feels to write, is what keeps a portfolio of registrations affordable.

Insight two: problems in the administrative module are the most underestimated. The difficulty of administrative documents lies not in their content but in their chain. A power of attorney passes through notarization, legalization (apostille or consular legalization) and translation, three steps. A certificate of free sale passes through issuance, legalization and translation, again three steps. Each step has its own validity period, and the shortest link in the chain sets the usable window of the whole set. A dossier that is administratively perfect on the day of signing can be unusable six months later without a single page having changed.

Insight three: technical review concentrates on consistency, not on depth. The Venezuelan review does not demand technical documentation at the depth of the EU MDR or the US FDA, but it does require that the product name, model and intended use entered on the application form correspond exactly to the technical file, the labeling, the instructions for use and the certificate of free sale. Cross-document inconsistency is the main source of deficiency letters. Depth gaps are usually tolerated; a contradiction inside the file is not, because it prevents the reviewer from establishing what is actually being registered.

Insight four: customs classification has to be settled before the dossier is designed. Article 37 of Decreto N° 4.944 makes the classification outcome decisive for the legal regime that applies, and the applicable regime in turn defines which documents and which labeling obligations attach to the file. A sponsor that assembles the dossier first and resolves classification last may find that the entire administrative module was built for the wrong regime. Confirming classification early is therefore not a customs detail but a design input, and it belongs at the very start of the project timeline.

4. Practical recommendations

  1. Work in the order skeleton, administrative module, quality system module, product module, evidence module, and run a consistency check at the end of every step rather than only before submission.
  2. Maintain a cross-document consistency table covering four items: product name, model, manufacturer name and address, and intended use, compared item by item across every document in the file.
  3. Manage administrative validity on the earliest-expiry-first principle, with a warning set 3 months before the earliest expiry date in the chain.
  4. Number the dossier table of contents by module, so that the reviewer can locate material quickly and so that later renewals and variations can update one module instead of the whole file.

5. Verification checklist

  • □ The dossier is organized in the four-layer module structure and a module table of contents has been compiled
  • □ The cross-document consistency table is complete (name, model, manufacturer, intended use)
  • □ All three steps of the administrative chain (notarization, legalization, translation) are complete and within validity
  • □ The scope of the quality system certificate covers this product and the certificate has not expired
  • □ The validity of the evidence module covers the expected review period

Regulatory information verified as of October 29, 2026.

For a product-specific feasibility assessment of Venezuela market entry, GRZAN’s regulatory team supports manufacturers, importers and authorized representatives with registration dossiers, conformity documentation and submissions to the Venezuelan health authority. Contact info@grzanglobal.com to discuss your project.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail